Immunotherapy data heralds new era of lung cancer treatment

A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumour cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress.

For decades, scientists and doctors thought immunotherapy – treatments that harness the immune system to fight a disease – was of marginal benefit in lung cancer, says Jean-Charles Soria, Institute Gustave Roussy in Paris, France.Continue reading